Pneumonia in allogeneic stem cell transplantation recipients: A multicenter prospective study

Clinical Transplantation

Volumn 25, Issue 6, 2011, Pages

  Aguilar Guisado, Manuela ^a   Jiménez Jambrina, Margarita ^a   Espigado, Ildefonso ^a   Rovira, Montserrat ^b   Martino, Rodrigo ^c   Oriol, Albert ^d   Borrell, Nuria ^e   Ruiz, Isabel ^f   Martín Dávila, Pilar ^g   de la Cámara, Rafael ^h   Salavert, Miquel ⁱ   de la Torre, Julián ^j   Cisneros, José Miguel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA FE   (Spain)

^j HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

more..

Author keywords

Epidemiology; Multicenter studies; Pneumonia; Post transplant infections; Stem cell transplantation

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; COTRIMOXAZOLE; CYCLOSPORIN A; FLUCONAZOLE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; LEVOFLOXACIN; METHOTREXATE; VALGANCICLOVIR;

ACUTE LEUKEMIA; ACUTE RESPIRATORY FAILURE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLUS; BACTERIAL PNEUMONIA; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG WITHDRAWAL; ESCHERICHIA COLI; FEMALE; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; INCIDENCE; INFECTION RATE; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; MULTICENTER STUDY (TOPIC); MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONHUMAN; OUTCOMES RESEARCH; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTIC SHOCK; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VIRUS PNEUMONIA;

ADULT; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84860409770     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01495.x     Document Type: Article

References (43)

1. Yoo JH, Lee DG, Choi SM et al. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transplant 2004: 34: 497.
2. Dettenkofer M, Wenzler-Röttele S, Babikir R et al. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis 2005: 40: 926.
3. Yamasaki S, Heike Y, Mori S et al. Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens. Transpl Infect Dis 2008: 10: 252.
4. Sakaida E, Nakaseko C, Harima A et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood 2003: 1: 102.
5. Meyer E, Beyersmann J, Bertz H et al., ONKO-KISS Study Group. Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation. Bone Marrow Transplant 2007: 39: 173.
6. Jinta M, Ohashi K, Ohta T et al. Clinical features of allogeneic hematopoietic stem cell transplantation-associated organizing pneumonia. Bone Marrow Transplant 2007: 40: 465.
7. Yoshihara S, Yanik G, Cooke KR, Mineishi S. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007: 13: 749.
8. Bjorklund A, Aschan J, Labopin M et al. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation. Bone Marrow Transplant 2007: 40: 1055.
9. Khayyata S, Soubani AO, Bonnett M, Nassar H, Abidi MH, Al-Abbadi MA. The major autopsy findings in adult patients after hematopoietic stem cell transplantation. Ann Transplant 2007: 12: 11.
10. Sharma S, Nadrous HF, Peters SG et al. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest 2005: 128: 1385.
11. Neofytos D, Horn D, Anaissie E et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009: 48: 265.
12. Alangaden G, Wahiduzzaman M, Chandasecrar P, the Bone Marrow Transplant Group. Aspergillosis: the most common community-acquired pneumonia with gram-negative bacilli as copatogens in stem cell transplant recipients with graft-versus-host-disease. Clin Infect Dis 2002: 35: 659.
13. Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant 2003: 9: 543.
14. Forslöw U, Mattsson J, Ringden O, Klominek J, Remberger M. Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation. Scand J Infect Dis 2006: 38: 970.
15. Gentile G, Micozzi A, Girmenia C et al. Pneumonia in allogenic and autologous bone marrow recipients. A retrospective study. Chest 1993: 104: 371.
16. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974: 18: 295.
17. De La Cámara R, Bischofberger C, Campins M, Carreras E. Immunization after hematopoietic stem cell transplantation: review and recommendations. Subcommittee of the Spanish Group on Infectious Complications in Hematopoietic Transplantation (GETH) and the Spanish Society of Preventive Medicine, Public Health and Hygiene. Med Clin (Barc) 1998: 110: 146.
18. De Pauw B, Walsh TJ, Donnelly JP et al., European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813.
19. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002: 34: 1094.
20. Rubin RH. Infection in the organ transplant recipient. In: Rubin RH, Young LS eds. Clinical Approach to Infection in the Compromised Host, 3rd edn. New York, NY: Plenum Medical Book Co., 1994: 629.
21. Guthrie KA, Yong M, Frieze D, Corey L, Fredricks DN. The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2010: 45: 675.
22. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001: 32: 1319.
23. Martino R, Subira M, Rovira M. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol 2002: 116: 475.
24. Kojima R, Kami M, Nannya Y et al. Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced intensity regimen compared with transplantation with a conventional regimen. Biol Blood Marrow Transplant 2004: 10: 645.
25. Morgan J, Wannemuehler KA, Marr KA et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005: 43(Suppl 1): S49.
26. Pagano L, Caira M, Nosari A et al. Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results of the SEIFEM B-2004. Study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007: 45: 1161.
27. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mold infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002: 34: 909.
28. Youssef S, Rodriguez G, Rolston KV, Champlin RE, Raad II, Safdar A. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005. Medicine (Baltimore) 2007: 86: 69.
29. Krowka MJ, Rosenow EC, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 1985: 87: 237.
30. Hoyle C, Goldman JM. Life-threatening infections occurring more than 3months after BMT. Bone Marrow Transplant 1994: 14: 247.
31. Chen CS, Boeckh M, Seidel K et al. Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003: 32: 515.
32. Atkinson K, Nivison-Smith I, Dodds A, Concannon A, Millieken S, Downs K. A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989. Bone Marrow Transplant 1998: 21: 691.
33. Machado CM, Dulley FL, Boas LS et al. CMV pneumonia in allogeneic BMT recipients undergoing early treatment of pre-emptive ganciclovir therapy. Bone Marrow Transplant 2000: 26: 413.
34. Nguyen Q, Champlin R, Giralt S et al. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients. Clin Infect Dis 1999: 28: 618.
35. Chemaly RF, Ghosh S, Bodey GP et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006: 85: 278.
36. Rodríguez Valín E, Hernández Pezzi H, Díaz García O. Casos de tuberculosis respiratoria y meningitis tuberculosa declarados a la Red Nacional de Vigilancia Epidemiológica. España, 2001-2002. Bol Epidemiol Semanal 2003: 11: 313.
37. De La Cámara R, Martino R, Granados E et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant 2000: 26: 291.
38. De Castro N, Neuville S, Sarfati C et al. Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study. Bone Marrow Transplant 2005: 36: 879.
39. Martín-Peña A, Aguilar-Guisado M, Espigado I, Parody R, Miguel Cisneros J. Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients. Clin Transplant 2011: 25: 468.
40. Nucci M, Andrade F, Vigorito A et al. Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation. Transpl Infect Dis 2003: 5: 167.
41. Cordonnier C, Ribaud P, Herbrecht R et al. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers. Clin Infect Dis 2006: 42: 955.
42. Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2007: 139: 519.
43. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002: 100: 4358.